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In this work, the bioaccessibility of polymethoxyflavones (PMFs) loaded in high internal phase emulsions (HIPE,
4oil ¼ 0.82) stabilized by whey protein isolate (WPI)-low methoxy pectin (LMP) complexes was evaluated using in
vitro lipolysis and dynamic in vitro intestinal digestion studies. PMFs loaded HIPE was prepared by using aqueous
dispersion of pre-formed biopolymeric complexes (WPI-LMP, 2:1 ratio) as the external phase and medium chain
triglycerides oil (containing PMFs extracted from citrus peel) as the dispersed phase. The in vitro lipolysis study
revealed that PMFs in HIPE became bioaccessible much higher than PMFs in medium chain triacylglycerols oil
(MCT oil). In addition, by simulating the entire human gastrointestinal (GI) tract, the GI model TIM-1 demon-
strated a 5- and 2-fold increase in the total bioaccessibility for two major PMFs encapsulated in HIPE, i.e. tan-
geretin (TAN) and nobiletin (NOB), respectively, as opposed to PMFs in MCT oil. Together these results from the
digestion study showed that the incorporation of a high amount of PMFs into the viscoelastic matrix of HIPE could
represent an innovative and effective way to design an oral delivery system. Such a system could be used to
control and to improve the delivery of lipophilic bioactive compounds within the different compartments of the
digestive tract, especially the human upper GI tract.1. Introduction
In recent decades, there has been a growing interest in flavonoids as
dietary bioactive compounds to prevent various diseases without adverse
effects (Xiao et al., 2016). Citrus flavonoids, especially polymethoxy-
flavones (PMFs) have been of particular interest because many of these
flavonoids demonstrate a wide spectrum of biological activity, including
anti-inflammatory, anti-carcinogenic, anti-bacterial, anti-oxidant, and
anti-nociceptive properties (Wang et al., 2014; Kim et al., 2016; Faqueti
et al., 2016; Gosslau et al., 2014a). PMFs are one type of flavonehok.patel@gtiit.edu.cn (A.R. Pate
ry Group, Department of Bioengin
evier B.V. This is an open access acompounds with several methoxy groups; more than 20 poly-
methoxylated flavonoids have been isolated and identified from different
tissues of citrus plants (Li et al., 2007).
PMFs are more lipophilic as compared to polyhydroxylated flavo-
noids, such as quercetin, luteolin, and naringenin, because of the hy-
drophobic nature of methoxy groups (Li et al., 2008). Therefore, the low
aqueous solubility of PMFs may impact their bioaccessibility and
bioavailability when they are digested. Since PMFs are highly lipophilic,
enhancing their solubility is essential to increase the bioaccessibility
(Ting et al., 2015a). Moreover, PMFs tend to easily crystallize in oill), paul.vandermeeren@ugent.be (P. Van der Meeren), qhuang@sebs.rutgers.edu
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(5-hydroxytangeretin) in medium chain triacylglycerols (MCT, 6.1 mM)
is higher than in long chain triacylglycerols (LCT, 4.2 mM) (Li et al.,
2012a). Thus, a high ratio of PMFs to dissolution medium is desirably to
prevent the crystallization of PMFs as well as to improve the loading dose
of PMFs for a specific therapeutic effect. A stable formulation with a high
lipid fraction, i.e. a high internal phase emulsion (HIPE), could be a
possible approach to improve the bioaccessibility of PMFs during
digestion events including the formation of micelles by bile salts and
endogenous phospholipids. The use of HIPE-based delivery systems for
flavonoids is still rather limited and needs to be further explored, since
they could be an effective strategy to improve the bioaccessibility of
flavonoids.
A few works on the impact of biopolymer coating on lipophilic
compounds delivery under digestion simulation have been published
(Mun et al., 2006; Tokle et al., 2012). The deposition of a layer of
non-digestible polysaccharides (i.e. chitosan) onto the surface of oil
droplets could modulate the in vitro digestion of the lipid and the fatty
acid release. The lipase activity on the emulsified lipid droplets was
reduced due to the formation of a relatively thick layer of biopolymer
complexes (lecithin-chitosan complexes) around each droplet (Mun
et al., 2006). It was also observed by Lesmes and McClements (Tokle
et al., 2012), that the conjugated high-molecular weight polysaccharide
to the protein provided a more stable emulsion that could resist to the
addition of bile by providing electro-steric stabilization. On the other
hand, simple emulsifiers could be easily displaced by bile. These studies
highlight the potential for protein-polysaccharide coatings to be used to
modulate the bioavailability of encapsulated lipids.
The bioaccessibility studies on major PMFs (especially TAN and NOB)
are very limited. One study in rats showed that after 1 h of oral adminis-
tration of 50mg/kgNOB, amere 1.78 μg/mL (4.4 μM) of plasmaNOBwas
detected (Singh et al., 2011). Therewas a studydemonstrating thatNOBat
a concentration of5 μMexhibited anti-proliferative effects against colon
cancer cells (Manthey and Guthrie, 2002). Furthermore, oral supple-
mentation of PMFs from orange peel extracts in a mice paw edema model
significantly reduced inflammation in a dose-dependent manner. It is re-
ported that a dosage of 250 mg/kg gave an anti-inflammatory effect
comparable to ibuprofen (Gosslau et al., 2014b).
PMFs are also rapidly eliminated from the body. Significant adverse
effects including toxicity at a relatively high concentration reported after
administration of PMFs are rare. In addition to this, the poor solubility of
these PMFs limits their bioaccessibility in the human gut system, which
eventually leads to a poor bioavailability and reduces the therapeutic
dosages they can achieve in the target organs. Some researchers also
attempted to improve the bioavailability of PMFs using a chemical
modification strategy (Tung et al., 2016). However, this approach is less
preferable concerning the safety and acceptance. The use of an encap-
sulation strategy is more desirable in this context than a chemical
modification approach.
Moreover, the encapsulation approach by incorporating a high
amount of PMFs in a lipid-rich system stabilized by food-grade complex
particles was hypothesized to improve their oral bioaccessibility. An
understanding of the bioaccessibility of PMFs becomes even more crucial
to assisting in the prediction of bio-efficacy through an in-vitro digestion
model that resembles the human digestion system.
An advanced in vitro digestion model using a computer programming
system to control relevant physiological parameters such as body tem-
perature, gastric and intestinal pH curves, peristaltic movements, phys-
iological intestinal volumes, and appropriate secretion of gastrointestinal
(GI) fluids, may closely resemble the in vivo digestion system (Minekus
et al., 2015). These in vivo parameters are essential to predict the
behavior under in vivo exposure and to quantify the compound that be-
comes bioavailable for absorption or bioaccessible (Lyng et al., 2016;
Naylor et al., 2006).
In this work, PMFs isolated from citrus peel powder were loaded in
HIPE stabilized by WPI-LMP complexes (HIPE-complexes) and the PMFs12bioaccessibility was evaluated. In our previous study, we have success-
fully formed ultra-stable HIPEs by optimizing the formation of bio-
polymeric complexes from WPI and LMP (Wijaya et al., 2017a). To our
knowledge, little is known about the impact of the HIPE-complexes
system on the intestinal absorption of PMFs. The bioaccessibility of
PMFs may be improved when delivered within systems rich in lipids. The
responsiveness of HIPE-complexes loaded with PMFs to simulated
digestion was investigated using in vitro pH-stat lipolysis and an in vitro
dynamic digestion model (TIM-1). The methodology used in this study
could provide more insight before performing in vivo studies to further
understand the impact of a stable HIPE-complexes system on the oral
bioavailability of PMFs. Such systems could be used to deliver bioactive
compounds in HIPE-based food products such as mayonnaise which
could then be used as functional foods.
2. Materials and methods
2.1. Materials
A minimally heat-treated whey protein isolate (WPI), enriched in
β-lactoglobulin (approx. 85% of total protein), was obtained from
Davisco Foods International, Inc. (Agropur, CA). According to the
manufacturer, theWPI sample contained92% protein, 6%moisture,
 4.5% minerals,  0.2% fat, and 0.2% lactose. Unipectine OB700 - a
low methoxy apple pectin with a DE between 33 and 38% was received
from Cargill R&D (Vilvoorde, Belgium). Neobee 895 Medium Chain
Triglyceride (MCT), 97% caprylic triglycerides, was received from Ste-
pan Company (Northfield, IL). Citrus peel powder was obtained from Dr.
Qingrong Huang's laboratory (Rutgers University, NJ). Tangeretin
(TAN) and nobiletin (NOB) standard (98% purity) were obtained from
Herb-key Botanical Development Co. (Shaanxi). Tris maleate, silica gel,
sodium chloride, calcium chloride dihydrate, potassium dihydrogen
phosphate, sodium azide, hydrochloric acid, and sodiumhydroxidewere
purchased from Sigma Aldrich (St. Louis, MO). Sodium taurodeox-
ycholate (NaTDC) was purchased from CalBiochem (La Jolla, CA).
Phosphatidylcholine (PC75 rapeseed lecithin) was a gift from the
American Lecithin Co. (Oxford, CT). Pancreatin of 8USP specification,
pepsin A from porcine stomach mucosa (2500–3500 units/mg, P-7012),
trypsin from bovine pancreas (7500 N-a-benzoyl-L-arginine ethyl ester
(BAEE) units/mg, T9201), and α-amylase Type II-A from Bacillus species
(1333 units/mg A-6380) were obtained from Sigma-Aldrich (Sigma-
Aldrich, St. Louis, MO). Fresh pig bile was obtained from TNO Zeist,
Netherlands. Rhizopus lipase (150,000 units/mg F-AP-15) was obtained
from Amano Enzyme Inc. (Nagoya). HPLC-grade acetonitrile (ACN) and
HPLC-grade water were purchased from J.T. Baker (Phillipsburg, NJ).
Sterile filtered, cell culture compatible dimethyl sulfoxide (DMSO)
(Sigma-Aldrich, St. Louis, MO) was used as HPLC sample solvent.
Distilled water was used in this study. All reagents were used without
further purification or modification, and all samples were formulated
and reported on a weight-by-weight basis (g/g).
2.2. Isolation and characterization of PMFs
PMFs were extracted using ethyl acetate at a 5:1 ratio of solvent to
citrus peel powder. The mixture was stirred for 2 h and sonicated 1 h.
Afterwards, the extract was filtered using a filter paper (0.45 μm) to
separate the supernatant from the precipitate. The precipitate was then
subjected to another extraction process by adding the same volume of
ethyl acetate. The supernatants obtained were mixed together followed
by evaporation of solvent to obtain a concentrated extract. Subsequently,
the concentrated extract was slowly poured down into a silica gel column
wetted by hexane. The silica gel column (2-inch diameter and 24-inch
length) was filled by 440 g of silica gel with particle size of 100–200
mesh. The ethyl acetate extract was poured onto the top of the column.
The extract passed through the column due to the gravitational force,
resulting in a brown and yellow band. The brown band was retained in
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yellow precipitates were collected, while the mixture of mobile phase
solvents was evaporated. After the evaporation, some essential oils still
remained in the sample because of their high solubility in ethyl acetate.
The essential oils were removed by adding hexane at a ratio 1:5 followed
by sonicating for 2 h, because PMFs are insoluble in hexane at room
temperature. The PMFs were then recovered by filtration followed by
recrystallization in hexane to remove other impurities including the
remaining essential oils. Briefly, recovered PMFs powder (50 mg) was
added into 10 mL of hexane followed by boiling at 130 C for 1–2 min to
completely dissolve the PMFs. Hot filtration was performed. The filtrate
was allowed to slowly cool down at room temperature to promote crystal
formation. Eventually, the yellow bright crystals of PMFs were recovered
using a filter paper. The microscopy images of PMFs powder before and
after recrystallization in hexane are shown in Fig. S1 (Supplementary
Information).2.3. HPLC analysis
PMFs were identified by using an UltiMate 3000 HPLC system
equipped with a 25D UV-VIS absorption detector (Dionex, CA) and a
Supelco RP-amide column, 15 cm  4.6 mm I.D., 3 μm particles (Bel-
lefonte, PA). The elution of PMFs was performed using a gradient of
water (solvent A) and ACN (solvent B). The optimized conditions were
modified from previous literature (Gosslau et al., 2014b). The total
elution time was 22 min, where the mobile phase started from 40% of
ACN, then linearly increased to 55% over 10 min, then increased to
70% in 5 min, and then to 80% in 5 min, and was then linearly reduced
back to 40% at 21 min and held isocratically for the final minute. The
flow rate was held constant at 1.0 mL/min, injection volume was 10 μL
and the detection wavelength was 320 nm. The PMFs standards, i.e.
TAN and NOB (98% purity), were injected into the column using the
same elution scheme as a reference. The concentration of TAN and NOB
in the sample was calculated from their standard curve at a concen-
tration ranging from 1 to 150 μg/mL.2.4. Loading of PMFs into HIPE stabilized by WPI-LMP complexes
WPI and LMP dispersion were mixed together to achieve 2.5% and
1.25% final concentration in HIPE. Hence, WPI-LMP complexes were
prepared by dissolving WPI and LMP powder in an aqueous phase con-
taining 0.02% sodium azide at a concentration of 10% and 5%, respec-
tively. This complex dispersion was adjusted to pH 5.25 by 1 and 0.1 N
hydrochloric acid for promoting electrostatic complexation. The aqueous
phase of the HIPE was kept constant at 20%, and 80% oil phase. To
evaluate the effect of the PMFs loading concentration on the bio-
accessibility in the emulsion, 2% PMFs were added to the carrier oil, and
dissolved at 130 C with continuous stirring until they were completely
dissolved (for 5 min). After the PMFs loaded oil reached a temperature of
about 30 C, the aqueous phase containing WPI-LMP complexes was
added to the oil phase. HIPEs were homogenized for 3 min at 6000 rpm
using a T25 digital ULTRA-TURRAX® (IKA-Werke GmbH & Co. KG,
Germany) equipped with a dispersing rotor S25N-10G. The resulting self-
standing emulsion gels were then stored at 5 C prior to analysis on the
following day.2.5. Particle size analysis of WPI-LMP complexes
The mean particle size and polydispersity index (PDI) of the WPI-LMP
complexes were determined using a Zeta-sizer Nano-ZS90 instrument
(Malvern Instruments Worcestershire, UK), and the mean particle size
was calculated from the z-average diffusion coefficient by the Stokes-
Einstein equation. The WPI-LMP dispersion at pH 5.25 was diluted 20
times to avoid multiple light scattering effects.132.6. Microstructure of PMFs-loaded HIPE-complexes
The microstructure of PMFs-loaded HIPE-complexes was analyzed by
using a Nikon Eclipse TE2000-U (Nikon Corporation, Japan) microscope
equipped with a charge-coupled device (CCD) camera (Retiga EXi,
QImaging). The sample was placed on a glass microscopic slide with a
cover glass.
2.7. In vitro lipolysis study
In vitro lipolysis was carried out according to our previously published
method (Yu et al., 2012). In short, a lipolysis buffer was prepared with
Tris maleate, sodium chloride, calcium chloride dihydrate, sodium
taurodeoxycholate, and phosphatidylcholine in concentrations of 50,
150, 5, 20, and 5 mM, respectively. Pancreatin was freshly prepared for
each study by mixing 1 g of pancreatin powder with 5 mL lipolysis buffer
and centrifuging at 2000 rpm for 10 min; the supernatant was collected
and stored on ice. To begin the lipolysis study, a sample containing
250 mg oil phase was mixed with 9 mL of fed state buffer in the glass
reaction vessel, which was put in an oil bath with temperature main-
tained at 37 1 C. The mixture was stirred at 200 rpm for 10min and its
pH was monitored by a pH meter. Before 1 mL of ice-chilled pancreatin
was added to initiate the digestion, the pH of the mixture was adjusted to
7.50  0.02 by adding 0.2 M sodium hydroxide solution. This tempera-
ture and pH were maintained during the lipolysis study to neutralize the
free fatty acids (FFA) released from the lipid digestion. The volume of
sodium hydroxide added at each time point was recorded for later
analysis. The percentage of FFA released was calculated using eq. (1):
%FFA¼ 100 VNaOH  mNaOH Mwlipid
Wlipid  2 (1)
VNaOH is the volume of titrant in liters, mNaOH is the molarity of sodium
hydroxide, Mwlipid is the apparent molecular weight of MCT oil obtained
from eq. (2), and Wlipid is the weight of oil in the digestion system in
grams. Molecular weight of the triglycerides was estimated using the
saponification value (SV) of the MCT oil (97% caprylic triglycerides), i.e.
384.
Mwlipid ¼ 3 1000 Mol: Weight of KOHSV (2)
Immediately upon completion of the lipolysis study, the resulting
lipolysis solutions were subjected to ultracentrifugation (Type 60 Ti
rotor, Beckman Coulter) for 40 min at 40,000 rpm. After ultracentrifu-
gation, the digestion medium was separated into an opaque sediment
phase, an aqueous phase containing formulated PMFs micelles in the
middle, and an oil phase at the top. The micelle phase was collected using
a syringe and the volume was recorded. For HPLC analysis, 200 μL of
lipolysis supernatant sample (0.22 μm filtered) was mixed with 400 μL of
DMSO. The concentration of PMFs in the micelles was analyzed using
HPLC. The bioaccessibility (%) of PMFs was calculated using eq. (3):
Bioaccessibilityð%Þ¼ total mass of solubilized PMFsðgÞ
total mass of PMFs in original lipid sampleðgÞ  100%
(3)
2.8. Dynamic in vitro GI model
To mimic physiological states, the secretion of digestive juices and
adjustment of pH conditions were controlled by computer programs ac-
cording to physiological data described in previous literatures (Ting et al.,
2015b; Ribnicky et al., 2014). The half-life of gastric emptying was set at
70 min. The temperature during the digestion simulation was maintained
at 37 C. The pH was regulated by secretion of hydrochloric acid in the
stomach and sodium bicarbonate in intestinal compartments, i.e. stomach
(pH1.5), duodenum(pH6.4), jejunum(pH6.9) and ileum(pH7.2). Lipase
W. Wijaya et al. Current Research in Food Science 2 (2020) 11–19andpepsinwereused for the gastric phase (reducing the pH from5.5 to 1.5
with a half time of 40min). The pancreatin and bile extract (fresh pig bile)
were secreted in the intestinal digestions. Hollow fiber filtration devices,
composed of semi-permeable membranes (0.05 μm pore size, Spectrum
MilikrosmodulesM80S-300-01P), were connected to the jejunal and ileal
compartments to simulate absorption of released/digested water or
fat-soluble compounds less than 50 nm in size.
TIM-1 was used to evaluate the bioaccessibility of PMFs in HIPE-
complexes and MCT oil (2% PMFs with respect to the oil content) in
simulated fed-state digestion. The formulation ‘meals’ (300 g) were a
mixture of sample (7.7 g) containing PMFs (124 mg), 95 g gastric elec-
trolyte solution, 0.011 g amylase, 5 g gastric enzyme solution and 180 g
water. Each compartment was first filled with defined start residues that
resemble the actual physiological GI conditions. All system conditions
used are summarized in Table 1.
The final mixture was introduced in the gastric compartment of TIM-1
and digestion was initiated. The physiological conditions of upper GI
digestion were mimicked and programmed according to the parameters
in Table 1; enzymes and GI fluids were continually secreted into the
stomach and duodenum compartment, based on the TIM-1 computer-
controlled settings. Each TIM-1 digestion experiment was terminated at
4 h when approximately 80% of the stomach contents had passed the
ileocaecal valve of the model and become the ileal efflux. Bioaccessibility
of PMFs was evaluated by collecting 40 mL of jejunum, ileum filtrate and
ileal efflux sample in 1 h intervals for 4 h after initiation of digestion.
Collected samples were stored on ice until subsequent HPLC analysis.
For HPLC analysis, 5 mL of sample was then extracted by mixing with
5 mL of ethyl acetate and centrifuged at 15,000 g for 30 min at ambient
temperature. After being centrifuged, the extract was purged using ni-
trogen to evaporate the solvent. The dried extract was mixed with 500 μL
of methanol for use in HPLC analysis (section 2.3). The amount of two
major PMFs in the samples, i.e. TAN and NOB, which was available for
absorption was calculated based on its concentration in the dialysis
fluids. In addition, the bioaccessibility of TAN and NOB (defined as % of
input) was calculated as a percent relative to the initial concentration of
TAN/NOB in HIPE-complexes and MCT oil samples.2.9. Statistical analysis
All experiments were conducted in triplicate, while the whole TIM-1
study was conducted in duplicate, in which each sample was analyzed in
three repetitions. Results were expressed as the mean  standard devi-
ation (SD). Error bars on figures represent standard deviations.
3. Results and discussion
3.1. Isolation and characterization of PMFs
PMFs were extracted from citrus peel powder using ethyl acetate as
solvent, followed by isolation and recrystallization of PMFs to removeTable 1
Established parameters of GI digestion in the TIM-1 for simulating digestive conditio
Gastric phase Small intestinal phase
Duodenum
Start residue Gastric enzyme solution: 5 g Small intestinal electrolyte soluti
Pancreatin solution: 15 g
Bile: 30 g
Trypsin solution (2 mg/cup): 1 c







0.25 ml/min of 1.5 M
HCl if necessary
0.5 ml/min bile salts
(4% during the first 30 min of di
0.25 ml/min pancreatic solution
0.25 ml/min SIES
0.25 ml/min 1 M NaHCO3 if nec
14essential oils and other impurities. The isolation process of PMFs yielded
about 3% from the citrus peel powder. PMFs were identified by HPLC
conducted using step gradient elution that enabled a clear separation of
individual PMFs. The HPLC chromatogram of the isolated PMFs is pre-
sented in Fig. S2 (supplementary information). The major PMFs in citrus
peel extract, i.e. TAN and NOB, were identified using a 98% purity
standard of TAN and NOB (Fig. S3, S4, supplementary information). The
other minor PMFs, i.e. 5-DTAN (5-hydroxy-6, 7, 8, 40-tetramethoxy-
flavone) and 5-DNOB were identified by their retention time, i.e. 15.49
and 13.31 min, respectively, according to our previous works, (Gosslau
et al., 2014b). The relative peak areas (%) of TAN, NOB, 5-DTAN and
5-DNOB are 65.88  3.14, 23.19  1.73, 4.70  0.01, 5.94  0.81,
respectively.
3.2. Characterization of PMFs-loaded HIPE stabilized by WPI-LMP
complexes
HIPE stabilized by WPI-LMP complexes have been prepared accord-
ing to our previous research (Wijaya et al., 2017a). In this work, the
WPI-LMP complexes which were pre-formed at pH 5.25 had a Z-average
diameter of 350 nm. The aqueous phase containing pre-formed com-
plexes (20%) was homogenized with the oil phase (80%) containing
PMFs (2%). The final concentration of WPI, LMP, and PMFs in the HIPE is
2.5, 1.25, and 1.6%, respectively. The visual appearance and microscopic
images of PMFs encapsulated in HIPE stabilized by WPI-LMP complexes
and PMFs in MCT oil are shown in Fig. 1. The microscopic image of the
emulsion showed that there were no crystals of PMFs detected in the
emulsion at a concentration of 2% with respect to the oil content, which
indicated that the PMFs remained soluble after being encapsulated in the
HIPE. A relatively low ratio of PMFs toMCT oil as the dissolutionmedium
was important to prevent the crystallization of PMFs which may affect
their rate and extent of absorption. It is notable that when a high content
of PMFs is dissolved in bulk oil at high temperature, some PMFs will
recrystallize rapidly if the temperature returns to room temperature (Li
et al., 2012a; Yang et al., 2017). It has also been previously reported that
the absorption of crystalline compounds in the GI tract is typically
dissolution rate-limited (Wang et al., 2014; Xia et al., 2015). The use of
high oil fraction in this study improved the loaded amount of the isolated
PMFs without any evidence of PMFs crystals two days after preparation
(data not shown).
3.3. Bioaccessibility of PMFs using the pH-stat lipolysis digestion model
pH stat-lipolysis has been previously used to study the lipid digestion
affecting the bioaccessibility of lipophilic compounds (Li et al., 2011;
Chen et al., 2017; Calligaris et al., 2015). During the lipid digestion, fatty
acids are continuously released, causing a pH decrease. The optimum pH
of the digestion was maintained by the addition of sodium hydroxide, so
that the kinetics of lipid digestion could be monitored. Free fatty acids
bound with the lipophilic compounds were further processed into lipidns of a healthy adult after meal intake.
Jejunum Ileum
on (SIES): 15 g
up
SIES: 40 g
Pancreatin solution: 40 g
Bile: 80 g
SIES: 160 g





0.25 ml/min 1 M
NaHCO3 if necessary
10 mL/min ileal fluid solution
0.25 ml/min 1 M NaHCO3 if
necessary
Fig. 1. HIPE-complexes (left) and MCT oil (right) containing 2% of PMF with respect to the oil content. The microscopic images were taken immediately after the
preparation of the samples. Bar scale is 20 μm. Inset: Photographs of respective samples.
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as a container for lipids and the bioactive compounds, will be collectively
transported to epithelium cells for absorption. The amount of bioactive
compounds incorporated into the micelles was quantified to determine
their bioaccessibility.
In this study, the titration kinetics of the HIPE sample proceeded at a
much faster rate than the bulk oil sample (Fig. 2). According to the % FFA
volume versus time curve, the majority of the lipid in the HIPE system
was digested within 10 min from the onset of the study and reached a
plateau after 40 min of digestion indicating that almost all lipid in the
HIPE-complexes has been digested. A higher final amount of FFAs
(105%) were released in the HIPE-complexes which this might be
attributed by a relatively high level of proteins in the sample. According
to previous work by Mun et al. (2015), the overestimation of % FFA was
found due to a relatively high content of mung bean which was presence
in the system. The digested protein may release peptides, amino acids,
and some protons (Hþ), thereby leading to an over-estimate of the actual
value of FFA released due to the neutralization of excessive protons by
sodium hydroxide.
On the other hand, the percentage of FFA released in bulk oil was
much lower (about 76% FFA released). The faster digestion kinetics of
the oil phase after being emulsified by WPI-LMP complexes was attrib-
uted to the greater surface area of emulsion droplets compared to the
bulk oil phase. It is also reported that the rate and extent of lipid digestion
plays an important role in the dissolution and bioaccessibility of lipo-
philic bioactives (Ozturk et al., 2015; Verwei et al., 2016). In agreement
with these studies, the improvement of lipid digestion in HIPE-complexes
resulted in an increase of the bioaccessibility of two major PMFs iden-
tified in the citrus peel extract, i.e. TAN and NOB.
The dissolution state of bioactive molecules in the lipid phase and
during the micellization is very important to ensure the availability of theFig. 2. Comparison of lipid digestion kinetics from PMFs-loaded HIPE-com-
plexes and PMFs in MCT oil expressed as the percentage of FFA as a function
of time.
15compounds for absorption in the epithelial cells of the small intestines. In
this lipolysis study, 2% PMFs were well dissolved which was a prereq-
uisite to have a good incorporation of PMFs in the formed micelles. The
presence of bioactive crystals might reduce the bioavailability of the
selected component due to the fact that they might not be absorbed in
this form into the GI tract. Besides, the crystals could also affect the
physical stability of the emulsion system (McClements, 2018). Fig. 3
reveals that the HIPE-complexes system improved the bioaccessibility of
two major PMFs (i.e. TAN and NOB) compared to the bioaccessibility of
those compounds in the bulk oil. The bioaccessibility of TAN and NOB as
the major PMFs in HIPE-complexes was approximately 2 and 1.5 fold
from this in the bulk oil, respectively. Ting et al. (Li et al., 2012a) re-
ported that the bioaccessibility of TAN in MCT oil was poor compared to
that in a 50% O/W emulsion system during a similar lipolysis study at
fasted state. In addition, NOB was observed to have a better solubility in
the oil phase compared to TAN at the original input concentration. Ac-
cording to Raman et al. (2005), NOB has more apolar characteristics due
to more methoxylated groups compared to TAN, which makes it more
soluble in the oil medium.
As a simplified digestion model, the pH-stat lipolysis model only
observed the lipid digestion based on sodium hydroxide titration into the
digestion buffer. This model may also control the pH, temperature, initial
endogenous bile salts and pancreatin concentrations for digestion.
However, some important factors in intestinal digestion events were
neglected such as intestinal transit, dynamic bile salts and enzymes
secretion, peristaltic movements, and absorption of digestion fluids. In
the next discussion, the bioaccessibility of the PMFs was evaluated using
TNO's GI model, a dynamic in-vitro digestion simulation, in which the
other important factors in human digestion events are well considered.
3.4. Bioaccessibility of PMFs using TNO's GI model
In this study, HIPE stabilized by WPI-LMP complexes and MCT oil
samples containing PMFs were fed into a computer programmed in vitroFig. 3. Bioaccessibility of PMFs (i.e. TAN and NOB) from HIPE-complexes and
MCT oil during 1 h pH-stat lipolysis.
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upper GI tract in which pre-absorption factors, such as temperature, pH,
gastric emptying time, enzymatic and bile salts concentrations, as well as
peristaltic movements, are controlled. These parameters should be
considered to significantly influence the amount of orally ingested nu-
trients or nutraceuticals that becomes bioavailable [33]. The samples
were collected after passing through semi-permeable capillary mem-
branes connected to the jejunum and ileum compartment to determine
the amount of PMFs that became available for absorption. From the
ileum, the digested samples were secreted through the ileal valve. The
samples were also collected to determine the amount of PMFs that was
theoretically delivered to the colon for further biotransformation or
metabolism.
The concentration of PMFs released from HIPE-complexes and MCT
oil at each intestinal section as a function of time is shown in Fig. 4.
Fig. 4A and C reveals that the concentration of TAN and NOB in HIPE
systems, gradually increased from 1 to 3 h at major sites of absorption,
i.e. jejunum and ileum. On the other hand, the bulk oil system showed a
quite low concentration of the two major PMFs in jejunum and ileum
(Fig. 4B and D). The concentration of PMFs for all samples in the ileal
efflux was also lower than that in previous absorption sites because most
of the PMFs had been absorbed in the jejunum and ileum. Overall, the
PMF concentrations in HIPE-complexes were higher than those in bulk
oil, suggesting that the HIPE-complexes system could protect PMFs from
the digestion by enzymes and severe acidic conditions of the gastric
compartment. Moreover, HIPE-complexes could also release PMFs
gradually from the emulsion in the intestinal compartments after oral
administration. The highest level of TAN and NOB was found in the
jejunum, indicating that this section was the main part for the absorption
in the small intestines, regardless of the type of system.
The cumulative bioaccessibility of TAN and NOBwas expressed as the
amount of TAN and NOB recovered from each absorption site relative to
the original input weight. Fig. 5 shows that the cumulative bio-
accessibility of TAN and NOB increased remarkably when they were
incorporated into the HIPE system as compared to the bulk oil. As shown
in Fig. 5, the mechanistic examination of TIM-1 suggested that theFig. 4. Concentration of TAN (line) and NOB (dash line) absorbed at jejunum (○), ile
HIPE-complexes samples.
16absorption of TAN and NOB majorly happened in the jejunum section
and was continuously eliminated from the system through efflux. The
results from the TIM-1 GI study indicated that the faster dissolution rate
of samples in the intestinal lumen could be greatly beneficial for
achieving a higher oral bioavailability, which can be achieved by
incorporating PMFs into a HIPE system. This observation was again
confirmed as the total cumulative bioaccessibility at two major absorp-
tion sites of TAN and NOB was 5- and 2-fold higher in the HIPE than in
the MCT oil sample, indicating that the HIPE-complexes that consisted of
80% oil could efficiently be loaded by a relatively high amount of PMFs.
The low ratio of PMFs to MCT oil as dissolution medium could also
prevent crystallization of PMFs since PMFs have a limited solubility in
MCT oil (Li et al., 2012a), suggesting the impact of solubility on the rapid
absorption and the higher bioaccessibility of PMFs.
During 3 h digestion of HIPE-complexes, the cumulative bio-
accessibility of PMFs increased significantly to about 24% and 34% for
TAN and NOB, respectively. As shown in Fig. 4, the concentration of TAN
and NOB in HIPE-complexes reached a peak followed by a decrease of the
concentration of both PMFs after 3 h digestion. Ribnicky et al. (2014)
studied the bioaccessibility of polyphenols during 4 h digestion: the
bioaccessibility reached a peak during 3 h digestion and decreased after
3 h. According to Lu et al. (2019), the bioaccessibility of curcumin in a
Pickering emulsion stabilized by starch particles increased significantly
to around 40% and leveled off after 4 h. Moreover, the release of over
30% of curcumin exhibited near-zero-order kinetics in the simulated
conditions, suggesting that the emulsion sample gives sustained release
of the encapsulated compound over a period of 4 h. In the
HIPE-complexes system, the oil droplets were coated by
protein-polysaccharide complexes (Wijaya et al., 2017a, 2017b). The bile
salts might have to replace the complexes before the digestive enzymes
could access the surface of the droplets. This restriction in the lipid hy-
drolysis would sustain the release of PMFs from the oil phase. Clearly, the
simulated conditions using TIM-1 were quite different from the in vitro
lipolysis study, where some essential parameters related to in vivo lipid
digestion were not considered resulting in a significant difference in the
evaluation of the PMFs’ bioaccessibility.um (Δ) and as an ileal efflux (□), as a function of time after feeding MCT oil and
Fig. 5. Cumulative in-vitro bioaccessibility of TAN and NOB in MCT oil was determined in jejunum, ileum and ileal efflux samples expressed as mean cumulative BA
of PMFs (% of input) for each compartment and standard deviation (SD) are presented as stacked bar graphs for each time point.
W. Wijaya et al. Current Research in Food Science 2 (2020) 11–19The higher bioaccessibility of TAN and NOB in the HIPE-complexes
system compared to that of both PMFs in the bulk oil sample was
mainly due to the accessibility of digestion enzymes because of the
greater surface area to volume ratio. Due to the greater surface area
available for digestion enzymes, the rate of mixedmicelle formation from
the digestion products was greater, as it was proven from the pH-stat
lipolysis study. Generally, the oil phase of formulations with medium-
chain TAGs can be completely digested during 1–2 h of pH-stat lipol-
ysis (Zhang et al., 2014). According to Sarkar et al. (2018) and Pilosof
(2017), the role of protein-polysaccharide complexes as emulsifier could
facilitate and modulate lipolysis as well as lipid absorption. In addition,
protein-polysaccharide complexes could also improve the lipophilic nu-
traceutical bioaccessibility compared to protein-stabilized emulsions
through the irreversible adsorption of the particles to the oil/water
interface, which are not easily displaced by bile salts as a bio-surfactant
(Sah et al., 2016). The interpolymeric gel network around the emulsion
droplets formed by electrostatic interactions could serve as a strong
mechanical barrier at the oil/water interface (Wijaya et al., 2018a,
2018b, 2019). In addition, the complexation of proteins with
non-digested polysaccharides like pectin might also hinder the disruption
of the droplet's surface by pepsin in the stomach (Qin et al., 2016). Hence,
intact droplets remained after gastric digestion, proven by the evidence
of efficient lipid digestion in HIPE-complexes compared toMCT oil due to
a larger surface area to volume ratio. According to Xu et al. (2014), the
stability against droplet flocculation and coalescence during gastric and
small intestine digestion was increased for the WPI–beet pectin com-
plexes and conjugate stabilized emulsion. Interestingly, this interpoly-
meric network showed a pH-responsive behavior, where it dissociates at
a high pH (Wijaya et al., 2017c). This behavior makes the emulsion
droplets physically stable towards coalescence and lipolysis under low
pH (around or below the isoelectric point of the protein) and releases the
oil droplets at pH conditions above the isoelectric point of the protein
during exposure at neutral pH of intestines.
WPI which formed a complex with LMP might be more resistant to
enzymatic digestion, especially to pepsinolysis at gastric pH. This17hypothesis is in close agreement to that of Li et al. (2012b) who reported
that chia protein-gum complexes and lactoferrin-pectin complexes were
able to protect the proteins from proteolysis. Furthermore, at the pH of
the small intestines, the pectin might (partly) become dissociated from
the complexes, which would made the lipid droplets more accessible to
proteolysis. The remaining complexes, free protein and pectin would be
further digested in the large intestines by microbiota and relevant en-
zymes. These protein and pectin metabolites are largely absorbed
through the large intestinal epithelial cells, while others are released in
feces in large amounts (Davila et al., 2013; Holloway et al., 1983).
4. Conclusions
In this work, we isolated PMFs from citrus peel powder and incor-
porated them into HIPE stabilized by WPI-LMP complexes. The WPI-LMP
complexes which had a Z-average diameter of 350 nm were used to
stabilize the HIPE (4oil¼ 0.82) resulting in a stable emulsion without any
evidence of coalescence as microstructurally observed. The bio-
accessibility of two major PMFs (i.e. TAN and NOB) in HIPE-complexes
and MCT oil (as a reference) was evaluated using an in vitro lipolysis
and a dynamic in-vitro digestion model. The in vitro lipolysis study
showed that the lipid in HIPE-complexes was digested faster than in MCT
oil, which resulted in a higher bioaccessibility of TAN and NOB in HIPE-
complexes than in MCT oil. However, a more adequate digestion simu-
lation which better represented the complexity of the human digestion
system was needed to provide a reliable and meaningful result for a
crystalline bioactive using a high fraction of the lipid-based delivery
formulation. According to the TIM-1 results, PMFs tended towards being
more bioaccessible when incorporated into the HIPE-complexes
compared to PMFs in MCT oil calculated from two major absorption
sites, i.e. jejunum and ileum. The improved digestion of the oil phase
greatly contributed to the release of both PMFs, which might explain the
higher bioaccessibility of the PMFs in HIPE-complexes. In vivo assessment
may still need to be conducted to further confirm the in vitro-in vivo
correlations since the advanced TIM-1 model also has some limitations: it
W. Wijaya et al. Current Research in Food Science 2 (2020) 11–19does not fully capture complex endothelial absorption events nor the
presence of microorganisms in the upper GI tract (Minekus et al., 2015).
Nevertheless, TIM-1 enabled the assessment of the impact of HIPE sta-
bilized by protein-polysaccharide complexes on the PMFs bioaccessibility
from gastric ingestion to pre-colonic delivery, whereby this assessment
could contribute to a more relevant comparison for the in vivo studies.
Moreover, this concentrated lipid-based delivery system could be used as
a strategy to ensure an optimal therapeutic bioactivity via a high loading
of lipophilic crystalline compounds.
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